Condition
Iliac Aneurysms
Total Trials
8
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
12.5%
1 terminated out of 8 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
4 of 4 completed with results
Key Signals
4 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Unknown3
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT02571907Not ApplicableCompleted
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
NCT02535065Not ApplicableCompleted
Zenith® Low Profile AAA Endovascular Graft
NCT02475798Unknown
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation
NCT01208415Not ApplicableCompleted
PRESERVE-Zenith® Iliac Branch System Clinical Study
NCT00833924Not ApplicableCompleted
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
NCT02557659Unknown
Zenith® Low Profile AAA Endovascular Graft
NCT02571985Unknown
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
NCT00893620Not ApplicableTerminated
Zenith(R) Connection Endovascular Covered Stent Clinical Study
Showing all 8 trials